Captrust Financial Advisors Arch Therapeutics, Inc. Transaction History

Captrust Financial Advisors

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 23, 2022	SELL	$0.04 - $0.1 $2,000 - $5,000	-50,000 Reduced 91.74%	4,500 $0
Q2 2020 Aug 14, 2020	BUY	$0.16 - $0.23 $8,720 - $12,535	54,500 New	54,500 $9,000

Ticker ARTH
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,886,000
Market Cap $50M
Description
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flag...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.